The feedback from this community outreach event in 2012 was very favorable. We plan to do it again, updating the community on research and treatment developments in several areas of neurology. The tentative date is Saturday, Noveember 2, 2013, beginning in the morning, again on UB’s North Campus. Topics will include stroke, memory disorders, multiple sclerosis, neuroimaging, and neuromuscular disorders.
The University at Buffalo’s Pediatric Multiple Sclerosis (MS) Center of Excellence will share in a $2.5 million National Multiple Sclerosis Society grant announced July 1.
UB MED Collaborations
A New Image of Multiple Sclerosis: UB Neurologists reveal key role of thalamus in the disease.
by Ellen Goldbaum
Neurologists at UB and their international collaborators have found that measuring atrophy of the thalamus using routine magnetic resonance imaging can be an important tool in detecting, evaluating, and predicting the course of multiple sclerosis.
Read it here: Dr. Zivadinov page 26
Dr. Robert Zivadinov and Dr. Ralph Benedict present findings about the important role of the Thalamus in MSPosted: March 24, 2013
Multiple Sclerosis research: The thalamus moves into the spotlight; Atrophy of the thalamus is an important predictor of clinically definite MS, study shows
By: Ellen Goldbaum
BUFFALO, N.Y. – A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and international partners is providing powerful new evidence that the brain’s gray matter reflects important changes in the disease that could allow clinicians to diagnose earlier and to better monitor and predict how the disease will progress.
Over the past three years, the UB researchers and their partners around the world, supported by an active fellowship program at UB’s Buffalo Neuroimaging Analysis Center (BNAC), have published journal papers and given presentations demonstrating that the thalamus region, in particular, is key to a host of issues involving MS.
“The thalamus is providing us with a new window on MS,” says Robert Zivadinov, MD, PhD, UB professor of neurology, BNAC director and leader of the research team. “In our recent studies, we have used large datasets to investigate the evolution of atrophy of the thalamus and its association with clinical impairment in MS, starting with the earliest stages of the disease. The location of the thalamus in the brain, its unique function and its vulnerability to changes wrought by the disease make the thalamus a critical barometer of the damage that MS causes to the brain.”
Zivadinov and UB professor of neurology Ralph Benedict discuss the new research in a video at (http://youtu.be/QhsaHeBjZrA).
At the annual meeting of the American Academy of Neurology today, Zivadinov will discuss a study he performed in collaboration with colleagues from Charles University in Prague. The study found that atrophy of the thalamus, determined with MRI, can help identify which patients with clinically isolated syndrome (CIS), a patient’s first episode of MS, are at risk for developing clinically definite MS. Such a tool would be immensely helpful to clinicians, Zivadinov notes.
Media Advisory: State Sen. Grisanti and UB researchers advocate state funding for NYS Multiple Sclerosis Registry and Consortium
WATCH THE SUPPORT:
BUFFALO, N.Y. — New York State Senator Mark Grisanti will join multiple sclerosis researchers at the University at Buffalo and patients to advocate for funding by New York State to maintain and expand the New York State MS Registry and the New York State MS Consortium, directed by Bianca Weinstock-Guttman, MD, UB professor of neurology.
When: 1 p.m., March 15, 2013
Where: UB’s Clinical and Translational Science Center, 5 floor, above the Gates Vascular Institute, 875 Ellicott Street, Buffalo
Why: MS Awareness Week runs from March 11 to 17. The incidence of MS in Western New York is twice the national average. The disease costs New York State between $1.5 and $2.3 billion each year. Support for the registry and consortium of 15 MS centers across the state will facilitate NYS research on MS, boost physician knowledge about the disease and improve the quality of life for the 30,000 New York State residents with MS.
Speakers will include:
· State Sen. Mark Grisanti, a member of the MS Legislative Alliance for the New York State Senate, and whose family has been affected by MS
· Bianca Weinstock-Guttman, MD, UB professor of neurology in the School of Medicine and Biomedical Sciences, and director of the NYS MS Registry
· Murali Ramanathan, PhD, UB professor of pharmaceutical sciences in the School of Pharmacy and Pharmaceutical Sciences and MS researcher
· An MS patient
Press arrangements: Ellen Goldbaum of UB University Communications at 645-4605 and 771-9255 onsite.
The ANNETTE FUNICELLO RESEARCH FUND FOR NEUROLOGICAL DISEASES is calling Mousketeer and Beach Party fans to support multiple sclerosis research by world-renowned MS researcher, Robert Zivadinov of the University at Buffalo.
Your gift will be matched up to $7,500 by the Annette Funicello Research Fund.
Your support will allow Dr. Zivadinov and his team at the Buffalo Neuroimaging Analysis Center to learn more about Pediatric Multiple Sclerosis.
To make a gift, go to: http://www.giving.buffalo.edu/funicello
For information about MS research at University at Buffalo by Dr. Zivadinov, go to: www.BNAC.net
For information about the Annette Funicello Research Fund for Neurological Diseases, go to: https://calfund.org/page.aspx?pid=638
If you want to distribute flyers for this excellent cause: Funicello Fund Flyer
Buffalo study offers hope to multiple sclerosis patients
Scientists in recent years have found a way to infuse stem cells into the brains of animals to repair damage to the central nervous system, offering some of the most encouraging news yet for multiple sclerosis patients.
Now, a key $12.1 million study soon will be under way in Buffalo and two other upstate medical centers that will for the first time begin to test the procedure in people.
The hope is that the stem cells will generate new myelin, the fatty substance that surrounds nerves like the insulation on a wire. Myelin is damaged in MS, leading to weak or lost signals between nerves. Eventually, the painful disease spreads in a slow, unpredictable path toward paralysis.
by: Henry Davis
Read about it: www.buffalonews.com
The state of New York has committed to fund the project through the stem cell fund.
Dr. Bianca Weinstock-Guttman, MD, co-principal investigator on the study, is Professor of Neurology, State University of New York at Buffalo, and Director of the Baird MS Center at The Jacobs Neurological Institute. She is also the Director of the Pediatric MS Center of the Jacobs Neurological Institute, one of six centers of excellence established by the National MS Society. In addition, she also serves as Executive Director of the New York State Multiple Sclerosis Consortium (NYSMSC).
Lawrence Wrabetz, MD, Professor of Neurology and Biochemistry and Director of the Hunter James Kelly Research Institute, has been named a University at Buffalo/SUNY Distinguished Professor. Only one other faculty member of the School of Medicine and Biomedical Sciences received the honorary title this year, which goes into effect September 1, 2014. Dr. Wrabetz joined the Dept. of Neurology in 2011, after being recruited from the San Raffaele Scientific Institute in Milan, Italy where he led the myelin biology program. Dr. Wrabetz’s research focuses on the biology and pathophysiology of myelin disorders in both the central and peripheral nervous system, including leukodystrophies and Charcot-Marie-Tooth disease. His laboratory studies several animal models to help understand how myelin, the protective coating lining the projections from neurons, is injured or fails to develop properly and what types of approaches may help reverse the process. His institute is named for Hunter James Kelly, a Western New York boy whose life was impacted by Krabbe Disease, a form of leukodystrophy.
Thomas Guttuso Jr,, MD, Associate Professor of Neurology, is continuing his work studying gabapentin in countering morning sickness or hyperemesis gravidarum associated with earlier stages of pregnancy. He will be conducting the first randomized, double-blinded study of the commonly used anti-seizure agent in a clinical trial supported by a $1.3 million grant from the National Institutes of Health. Dr. Guttuso is the Principal Investigator on the award. In prior pilot work published in 2010, Dr. Guttuso, who also holds an appointment in the UB Dept. of Obstetrics and Gynecology, showed that gabapentin, a relatively safe agent with essentially no drug-drug interactions or risk of congenital birth defects, reduced nausea and vomiting in women suffering from hyperemesis gravidarum by 80-95 percent. For more information see http://www.buffalo.edu/news/releases/2014/06/025.html.
The UB Dept. of Neurology held its annual Michael E. Cohen, MD, Residents Research Day and Graduation Banquet on June 13, 2014. All graduating residents presented their research findings, while the PGY-3 level residents presented research plans. The Research Day was coordinated by Dr. Robert Zivadinov and his staff. Winners of the Research Day Awards were Rajesh Gupta, PGY4 and Chief Resident, and Karanbir Singh, PGY3. The day’s program is attached. 2014 Research Day Program
Graduating residents were Cynthia Shin Beatty, Ahmad Abokhamis, Mahmoud Al Masry, Supriya Kohli, and Rajesh Gupta. Graduating neurophysiology fellows were Alyssa Fiddler, Salomi Salins, and Novreen Shahdad, and neuroimaging fellow Maria Serviole Verde. The incoming neurology chief residents for 2014-15 are Nour Abdelhamid and Pooja Sofat.
Ashkan Mowla, MD, Assistant Professor of Neurology, is the co-first author on a study published in Cerebrovascular Diseases (2014;37:277-284) on the value of cardiac MRI in identifying the etiology of acute strokes. The routine evaluation for the cause of stroke includes transthoracic echocardiography, but this standard technique has limited ability to detect some abnormalities in the heart or aorta that could contribute to stroke. Some one-third of strokes currently remain cryptogenic, meaning that no clear etiology is identified despite a full work-up. By adding MRI studies of the heart to the routine stroke evaluation in 106 patients, Dr. Mowla and his co-investigators were able to reduce the frequency of cryptogenic stroke by nearly 40%. In some cases, identification of the etiology impacted patient management. The authors cautioned that further study of the technique in larger groups of patients with longer follow-up is needed to confirm their preliminary findings.
Faculty and housestaff of the Dept. of Neurology presented over 25 abstracts at the 2014 Annual Meeting of the American Academy of Neurology (AAN), held in Philadelphia between April 26 and May 3. The AAN meeting is the largest conference focusing on neurological disorders held in North America each year. Attendees include American and international neurologists and neuroscientists, among others interested in neurological disease. Presentations were made during both platform and poster sessions. Topics of research by UB presenters included adult and pediatric multiple sclerosis, epilepsy, Parkinson’s disease, myasthenia gravis, neuroimaging, usage of intravenous gammaglobulin in neurological disorders, and improving communication during patient hand-offs in the hospital setting. For more information regarding the AAN meeting, please see http://www.abstracts2view.com/aan/.
Two UB Neurology faculty members, Drs. Ashkan Mowla and Mohammed Reza Samie, have received honorable mention in the 2014 Louis A. and Ruth Siegel Awards for Excellence in Teaching. The awards are given by the UB School of Medicine and Biomedical Sciences and recognize extraordinary educators who have served as role models to their students by stimulating thinking and demonstrating sensitivity toward the human condition. The presentation was held at the University at Buffalo South Campus on April 16th. Dr. Mowla joined the Department of Neurology less than a year ago after completing his fellowship in stroke and cerebrovascular diseases at the University of Michigan. He received honorable mention in the clinical faculty category. Dr. Samie, a volunteer faculty member, received honorable mention in the volunteers/special recognition category. He has been in practice for 42 years and is currently affiliated with the Buffalo VA Medical Center.
A new Toshiba Vantage 3 Tesla MRI scanner was hoisted 7 stories high into its new home at the University at Buffalo’s Clinical and Translational Research Center (CTRC) on April 12. The seven-ton machine was trucked from California to Buffalo on a specially designed tractor-trailer. The new MRI is a key piece of research equipment for the center, and will reduce the dependence of research imaging on other campus magnets that are primarily dedicated for clinical studies. One of the first research teams to use the new facility will be the Buffalo Neuroimaging Analysis Center (BNAC), a division of the UB Department of Neurology. Professor of Neurology Dr. Robert Zivadinov, MD, PhD, who directs the BNAC, serves as the director of magnetic resonance imaging for the CTRC. Ongoing and planned studies include development of MRI biomarkers for diagnosing , and managing neurological diseases such as Alzheimer’s disease, multiple sclerosis, stroke, and Parkinson’s disease.